<DOC>
	<DOCNO>NCT00395057</DOCNO>
	<brief_summary>This 24-month study evaluate multiple dos AGN211745 ( previously know Sirna-027 ) treatment subfoveal choroidal neovascularization associate age-related macular degeneration</brief_summary>
	<brief_title>A Study Using Intravitreal Injections Small Interfering RNA Patients With Age-Related Macular Degeneration</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Neovascularization , Pathologic</mesh_term>
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ranibizumab</mesh_term>
	<criteria>50 year old `` wet '' AMD determine ophthalmologist decrease visual acuity ( 20/40 20/640 ) least one eye Uncontrolled systemic disease History heart attack stroke within one year study entry Symptomatic coronary artery disease Cataracts interfere vision</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>